XTL Biopharmaceuticals Ltd. (XTLB) Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
4/16/2009 11:25:50 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Announces Financial Results for the Year Ended December 31, 2008
4/7/2009 10:34:04 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Extraordinary General Meetings Statement; Board and Management Changes
3/19/2009 10:54:27 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
3/19/2009 10:48:46 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Extraordinary General Meetings Postponed Until March 18, 2009
3/11/2009 10:48:44 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
2/12/2009 9:50:56 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter
2/6/2009 8:23:33 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Announces Receipt of NASDAQ Notice of Delisting
1/28/2009 10:35:38 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Provides Update on Potential Strategic Alternatives
1/28/2009 6:30:11 AM
More...
|
XTL Biopharmaceuticals Ltd. (XTLB) Implements Restructuring Plan; Terminating Employment of 75% of Workforce
12/9/2008 6:55:21 AM
More...
|
|